Faculty Bibliography

Purpose: To determine optimal (prone vs. supine) treatment positions for breast radiotherapy by classifying geometric features extracted from prone CT scans. Method and Materials: CT scans from patients enrolled in NYU 05‐181 Protocol were studied to discern predicting factors for optimizing treatment positions for breast radiotherapy. Each of the 400 patients accrued for this protocol underwent CT simulation and planning in both supine and prone positions. The treatment set up was chosen based on maximum sparing of heart and lung. Since the results demonstrated that most patients were best treated prone, we studied whether a support vector machine (SVM) classifier could successfully predict optimal position based on a single prone CT scan and limit a second supine CT only to the minority of women best treated supine. To build this classifier, prone CT scans of NYU 05‐181 were de‐identified and exported in DICOM RT format. Three‐dimensional shape and distance features were computed from organs at risk and the planning target volume in the CT scans. We used a k‐fold cross validation procedure to test the performance of the SVM classifier. Results: Images of 36 patients (23 prone‐treated and 13 supine‐treated) were used. Preliminary results indicate that breast volume, heart and lung involvement in the treatment field are significant predicting factors. A weighting of 1:5 (prone‐treated: supine‐treated) was used when determining the soft margin hyper plane of the SVM classifier. The purpose is to increase the specificity [true‐supine/ (true‐supine+false‐prone)] of the classifier since patients classified as prone will not receive a validation supine CT scan. A sensitivity [true‐prone/(true‐prone+false‐supine)] of 87% and a specificity of 92% was achieved using 11 geometric features and the SVM classifier. Conclusion: Preliminary data support the use of a feature‐based classification to predict the optimal treatment position from prone CT scans

BACKGROUND: We report the results of a prospective trial investigating the use of accelerated, hypofractionated whole-breast radiation therapy after breast-conservation surgery for ductal carcinoma in situ (DCIS). PATIENTS AND METHODS: A total of 59 patients with a median age of 54 years (range, 36-78 years) completed a phase I/II study of hypofractionated radiation therapy for treatment of DCIS. Eligibility criteria included patients with mammographically detected DCIS, status after segmental mastectomy with negative margins, and no residual calcifications. All patients were treated with external-beam radiation therapy without a boost, over 3 weeks, to a total dose of 42 Gy to the entire breast (2.8 Gy per fraction in 15 fractions). To optimally spare heart and lung, 34 of the 59 patients (57%) were treated in the prone position. Twenty-nine of 59 patients (49%) received adjuvant hormonal therapy. RESULTS: Overall, radiation therapy was well tolerated, with modest acute toxicity limited to grade 1 radiation dermatitis (76%), breast edema (17%), and fatigue (12%). With a median follow-up of 36 months, late toxicities included grade 1 hyperpigmentation changes (85%), induration (66%), asymmetry (64%), and breast fibrosis (17%), with 3 cases of grade 2 fibrosis and 1 case of grade 2 hyperpigmentation. Among the patients with >or= 3 years of follow-up, cosmesis was scored as good to excellent in 21 patients (91%) and fair in 2 patients (9%). At the time of this report, no ipsilateral or contralateral breast recurrences have occurred. CONCLUSION: These data demonstrate the feasibility of treating the whole breast for DCIS with a hypofractionated regimen, with modest acute and late toxicity